来自布氏锥虫亚种的基因组 DNA.罗得西亚

NR-50128??Trypanosoma brucei subsp. rhodesiense, Genomic DNA from Trypanosoma brucei?subsp. rhodesiense,?Strain KETRI 2537 (in vitro?procyclic form) (Nucleic Acids)|Trypanosoma brucei subsp. rhodesiense|Genomic DNA from Trypanosoma brucei?subsp. rhodesiense,?Strain KETRI 2537 (in vitro?procyclic form) |-20°C or colder|CJ BacchiAcknowledgment for publications should read “The following reagent was obtained through BEI Resources, NIAID, NIH: Genomic DNA from Trypanosoma brucei subsp. rhodesiense, Strain KETRI 2537 (in vitro procyclic form), NR-50128.”|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment. Genomic DNA was isolated from Trypanosoma brucei subsp. rhodesiense, strain KETRI 2537 (in vitro procyclic form; available as BEI Resources NR-50075). Strain KETRI 2537 (available as BEI Resources NR-46436, bloodstream form) was originally isolated in Busoga, Uganda, in 1972. The bloodstream form was harvested from the blood of infected BALB/c mice and adapted to cell culture by BEI Resources and extracted to produce NR-50128. NR-50128 has been qualified for PCR applications by amplification of approximately 1300 base pairs of the internal transcribed spacer (ITS) 1, 5.8S ribosomal RNA gene, ITS 2. Each vial of NR-50128 contains at least 3 ?g of genomic DNA in buffer. The vial should be centrifuged prior to opening. 

NR-49828??Trypanosoma brucei subsp. rhodesiense, Genomic DNA from Trypanosoma brucei?subsp. rhodesiense,?Strain KETRI 243 (in vitro procyclic form) (Nucleic Acids)|Trypanosoma brucei subsp. rhodesiense|Genomic DNA from Trypanosoma brucei?subsp. rhodesiense,?Strain KETRI 243 (in vitro procyclic form) |-20°C or colder|CJ BacchiAcknowledgment for publications should read “The following reagent was obtained through BEI Resources, NIAID, NIH: Genomic DNA from Trypanosoma brucei subsp. rhodesiense, Strain KETRI 243 (in vitro procyclic form), NR-49828.”|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment. Genomic DNA was isolated from Trypanosoma brucei subsp. rhodesiense, strain KETRI 243 (in vitro procyclic form; available as BEI Resources NR-49827). The bloodstream form of strain KETRI 243 (available as BEI Resources NR-46431) was originally isolated in Busoga, Uganda, in 1961. The bloodstream form was harvested from the blood of infected BALB/c mice and adapted to cell culture by BEI Resources and extracted to produce NR-49828. NR-49828 has been qualified for PCR applications by amplification of approximately 1300 base pairs of the large subunit ribosomal RNA sequence. Each vial of NR-49828 contains approximately 8 ?g of genomic DNA in 10 mM Tris-HCl, 0.5 mM EDTA, pH 9. The vial should be centrifuged prior to opening.